The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field

The clinical evaluation of convalescent plasma (CP) for the treatment of Ebola virus disease (EVD) in the current outbreak, predominantly affecting Guinea, Sierra Leone, and Liberia, was prioritized by the World Health Organization in September 2014. In each of these countries, nonrandomized compara...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: van Griensven, Johan, De Weiggheleire, Anja, Delamou, Alexandre, Smith, Peter G., Edwards, Tansy, Vandekerckhove, Philippe, Bah, Elhadj Ibrahima, Colebunders, Robert, Herve, Isola, Lazaygues, Catherine, Haba, Nyankoye, Lynen, Lutgarde
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Viewpoints
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4678103/
https://ncbi.nlm.nih.gov/pubmed/26261205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ680
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars